Primary cutaneous follicle center cell lymphoma of the scalp successfully treated with anti CD20 monoclonal antibody and CHOP combination therapy with no subsequent permanent loss of hair

Journal of Dermatology

Volumn 30, Issue 9, 2003, Pages 683-688

  Imai, Yasutomo ^a   Isoda, Ken Ichi ^a   Ito, Emiko ^a   Hakamada, Arata ^a   Yamanishi, Kiyofumi ^a   Mizutani, Hitoshi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Alopecia; B cell lymphoma; Primary cutaneous follicular lymphoma; Rituximab

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCLONAL ANTIBODY CD20; PREDNISOLONE; PROTEIN BCL 2; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; ELECTRON BEAM; FOLLICULAR LYMPHOMA; HAIR LOSS; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; MALE; MALIGNANT NEOPLASTIC DISEASE; REMISSION; SIDE EFFECT; SKIN LYMPHOMA; TUMOR LOCALIZATION;

EID: 0141995568     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2003.tb00458.x     Document Type: Article

References (9)

1. Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer, Blood, 90: 354-371, 1997.
2. Harris NL, Jaffe ES, Diebold J, et al: Conference report. The World Health Organization classification report. The World Health Organization classification and lymphoid tissues. Report of the Clinical Advisory Committee, Airlie House, Virginia, November 1997, Histopathology, 36: 69-87, 2000.
3. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group, Blood, 8: 1361-1392, 1994.
4. Gaulard P, d'Agay MF, Peuchmaur M, et al: Expression of the bcl-2 gene product in follicular lymphoma, Am J Pathol, 140: 1089-1095, 1992.
5. Mirza I, Macpherson N, Paproski S, et al: Primary Cutaneous Follicular Lymphoma: An assessment of clinical, histopathologic, immunophenotypic, and molecular features, J Clin Oncol, 20: 647-655, 2002.
6. Cerroni L, Kerl H: Cutaneous follicle center cell lymphoma, follicular type, Am J Dermatopathol, 23: 370-373, 2001.
7. Willemze R, Meijer CJ: EORTC classification for primary cutaneous lymphomas: A comparison with the R.E.A.L. Classification and the proposed WHO Classification, Ann Oncol 11 (suppl 1): 11-15, 2000.
8. Czuczman MS, Grillo-Lopez AJ, White CA, et al: Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy, J Clin Oncol, 17: 268-276, 1999.
9. Heinzerling LM, Urbanek M, Funk JO, et al: Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (Rituximab) in patients with primary cutaneous B-cell lymphoma, Cancer, 89: 1835-1844, 2000.